Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp V.QIPT


Primary Symbol: T.QIPT Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by lscfaon Feb 03, 2022 2:56pm
165 Views
Post# 34394414

Draft law to raise rates

Draft law to raise rates

WASHINGTON – AAHomecare is calling on providers to contact their members of Congress to sign on as original co-sponsors for draft legislation from by Rep. Markwayne Mullins, R.-Okla., and Paul Tonko, D-N.Y., that would provide reimbursement relief. 

The legislation would apply 90/10 blended reimbursement rates for the 13 product categories that were removed from Round 2021 of Medicare’s competitive bidding program. The rates would apply from Jan. 1, 2022, through Dec. 31, 2023. 

“A strong show of grassroots support at the open of this campaign will raise the visibility of this measure and re-affirm our industry’s passion and commitment to advocate for this legislation to our allies on the Hill,” says the association in a bulletin. 

AAHomecare is asking providers to send a brief, personally drafted e-mail to their representative’s staffer who deals with health care issues containing a couple of sentences about the critical need to align Medicare reimbursement rates with the cost and operational environment the industry faces. Also include: an ask that they serve as an original co-sponsor to the bill. 

Providers can find draft messaging and information about how to contact their legislators here, including details on finding the email for the staffer who handles health care issues, as well a list of legislators who joined a House sign-on letter last November asking CMS to address Medicare reimbursements for HME. 

AAHomecare has also provided a pre-drafted email through its Action Center. 


<< Previous
Bullboard Posts
Next >>